FDA Inspection 1088977 — Vitalant

Vitalant — FEI 1076019

The FDA completed an inspection of Vitalant on May 9, 2019 in Memphis, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 9, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Memphis, TN (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency